Zeynep Ural

ORCID: 0000-0002-3162-8760
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • COVID-19 and healthcare impacts
  • Renal Diseases and Glomerulopathies
  • Dialysis and Renal Disease Management
  • Autoimmune Bullous Skin Diseases
  • Nail Diseases and Treatments
  • Nutrition and Health in Aging
  • Cutaneous Melanoma Detection and Management
  • Genetic and rare skin diseases.
  • Vasculitis and related conditions
  • Renal and Vascular Pathologies
  • Viral Infections and Immunology Research
  • Hip and Femur Fractures
  • Transplantation: Methods and Outcomes
  • Renal cell carcinoma treatment
  • Neonatal Health and Biochemistry
  • Hedgehog Signaling Pathway Studies
  • Syphilis Diagnosis and Treatment
  • Body Composition Measurement Techniques
  • Hemodynamic Monitoring and Therapy
  • Renal Transplantation Outcomes and Treatments
  • Inflammasome and immune disorders
  • HIV-related health complications and treatments
  • Tuberous Sclerosis Complex Research

Gazi University
2022-2025

Türkiye Yüksek İhtisas Hastanesi
2025

Atatürk University
2024

Kırıkkale University
2023-2024

Gazi Hastanesi
2023

Istanbul University
2022

Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period not been published extensively.We conducted a national, multicenter observational study that included adult maintenance HD recovered from confirmed A control group without COVID-19 was selected in same center. We investigated characteristics follow-up compare them with non-COVID-19 group.A total 1223 (635 group, 588 group) 47 centers were...

10.1016/j.ekir.2022.03.017 article EN cc-by-nc-nd Kidney International Reports 2022-03-25

<b><i>Introduction:</i></b> We aimed to study the characteristics of peritoneal dialysis (PD) patients with coronavirus disease-19 (COVID-19), determine short-term mortality and other medical complications, delineate factors associated COVID-19 outcome. <b><i>Methods:</i></b> In this multicenter national study, we included PD confirmed from 27 centers. The baseline demographic, clinical, laboratory, radiological data outcomes at end first month...

10.1159/000526909 article EN cc-by-nc Kidney & Blood Pressure Research 2022-01-01

In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group.The primary endpoint was death in the third month. Secondary endpoints were ongoing respiratory symptoms, need for home oxygen therapy, rehospitalization any reason, lower tract infection, urinary biopsy-proven acute rejection, venous/arterial thromboembolic event, cytomegalovirus (CMV) infection/disease BK viruria/viremia at 3 months.A...

10.1093/ckj/sfac045 article EN Clinical Kidney Journal 2022-02-11

Introduction: There are not enough data on the post-CO­VID-19 period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare clinical and laboratory of PD after COVID-19 with a control group. Methods: This study, supported by Turkish Society Nephrology, is national, multicenter retrospective case-control study involving adult confirmed COVID-19, using collected April 21, 2021, June 11, 2021. A group was also formed each unit, similar characteristics but without...

10.1159/000526234 article EN ˜The œNephron journals/Nephron journals 2022-09-30

Abstract Background The SARS-CoV-2 pandemic has become the most serious health problem of today globally. Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common and associated high mortality. Although acute tubular necrosis due to hemodynamic instability cause, other complex destructive processes related cytokine storm activation innate adaptive immunity have also been reported. Case presentation: Herein, we present successful treatment proteinase-3 anti-neutrophil...

10.21203/rs.3.rs-2802716/v1 preprint EN cc-by Research Square (Research Square) 2023-05-26

Abstract Background and Aims Focal segmental glomerulosclerosis (FSGS) is a disease that among the primary glomerulopathies often progresses to chronic renal failure. Despite advances in immunosuppressive therapy for treatment of glomerular diseases, some FSGS patients are resistant single or combination regimens containing; glucocorticoids, cyclophosphamide, calcineurin inhibitors, mycophenolate mofetil (MMF), and/or rituximab. FSGS-related nephrotic syndrome, degree proteinuria response...

10.1093/ndt/gfad063c_2519 article EN Nephrology Dialysis Transplantation 2023-06-01

Abstract BACKGROUND AND AIMS Haemodialysis (HD) patients are at increased risk for adverse short-term consequences of COVID-19. In this study, we investigated the characteristics chronic HD in post-COVID-19 period and compared them with control group. METHOD We conducted a national multicentre observational study involving adult recovering from The group was selected similar who did not have COVID-19 same center. SARS-CoV-2 RT-PCR negative active were included. RESULTS A total 1223 (635...

10.1093/ndt/gfac066.068 article EN Nephrology Dialysis Transplantation 2022-05-01

Abstract BACKGROUND AND AIMS The SARS-CoV-2 pandemic has become one of the most serious health problems globally. Covid-19 poses a life-threatening risk, especially for immunocompromised patients such as kidney transplant recipients. However, reason why some recipients are asymptomatic while others severely ill is still not clear. Genetic variation might affect outcome and mortality infection. Haptoglobin (Hp) plasma protein with antioxidant, immunomodulatory properties an important...

10.1093/ndt/gfac087.041 article EN Nephrology Dialysis Transplantation 2022-05-01

Abstract BACKGROUND AND AIMS There is not enough data on the post-COVID-19 (coronavirus disease 2019) period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare clinical and laboratory retrospectively obtained in follow-up of PD after COVID-19 with a control group. METHOD This study, supported by Turkish Society Nephrology, national multicenter case–control study involving adult confirmed COVID-19, using collected 21 April 2021 11 June 2021. A group was also...

10.1093/ndt/gfac078.035 article EN Nephrology Dialysis Transplantation 2022-05-01

Abstract BACKGROUND AND AIMS Although existing data suggest an increased mortality rate, about the course of coronavirus disease 2019 (COVID-19) in peritoneal dialysis (PD) patients, its short- and long-term effects on patient technique survival are limited. Moreover, specific factors associated with risk death have not been clearly defined yet. Therefore, we aimed to study characteristics PD patients COVID-19, determine short-term other medical complications, delineate COVID-19 outcome....

10.1093/ndt/gfac078.033 article EN Nephrology Dialysis Transplantation 2022-05-01

Journal of the American Society Nephrology 33(11S):p 558-559, November 2022. | DOI: 10.1681/ASN.20223311S1558d

10.1681/asn.20223311s1558d article EN Journal of the American Society of Nephrology 2022-11-01
Coming Soon ...